bioRxivImmunologyPreprint
Knockout studies using CD34+ hematopoietic cells suggest that CD44 is a physiological human neutrophil E-selectin ligand
Abstract
The recruitment of peripheral blood neutrophils at sites of inflammation involves a multistep cascade, starting with E- and P-selectin expressed on the inflamed vascular endothelium binding sialofucosylated glycans on leukocytes. As the glycoconjugate biosynthesis pathways in different cells are distinct, the precise carbohydrate ligands of selectins varies both across species, and between different immune cell populations in a given species. To study this aspect in human neutrophils, we developed a protocol to perform CRISPR/Cas9 gene-editing on CD34+ hHSCs (human hematopoietic stem/progenitor cells) as they are differentiated towards neutrophil lineage. This protocol initially uses a cocktail of SCF (stem-cell factor), IL-3 (interleukin-3) and FLT-3L (FMS-like tyrosine kinase 3 ligand) to expand the stem/progenitor cells followed by directed differentiation to neutrophils using G-CSF (granulocyte colony-stimulating factor). Microfluidics based assays were performed on a confocal microscope platform to characterize the rolling phenotype of each edited cell type in mixed populations. These studies demonstrated that CD44, but not CD43, is a major E-selectin ligand on human neutrophils. The loss of function results were validated by developing sialofucosylated recombinant CD44. This glycosylated protein supported both robust E-selectin binding in a cell-free assay, and it competitively blocked neutrophil adhesion to E-selectin on inflamed endothelial cells. Together, the study establishes important methods to study human neutrophil biology and determines that sialoflucosylated-CD44 is a physiological human E-selectin ligand. KEY POINTSO_LIA CRISPR-Cas9 based protocol was optimized to knockout genes in primary human neutrophils derived from CD34+ hHSCs C_LIO_LIUnder physiological fluid shear conditions, a sialofucosylated form of CD44 expressed on human neutrophils is a major E-selectin ligand C_LI VISUAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=111 SRC="FIGDIR/small/553923v1_ufig1.gif" ALT="Figure 1"> View larger version (21K): org.highwire.dtl.DTLVardef@1891653org.highwire.dtl.DTLVardef@118e074org.highwire.dtl.DTLVardef@38052aorg.highwire.dtl.DTLVardef@1db0882_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: proteomics
- research focus: cell type annotation
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Efficient methods for target gene manipulation in haematopoietic stem cell derived human neutrophils.
A. Y. Ng, E. Fox, … C. Summers·bioRxiv·Jun 17, 2023
- Identification and characterization of human CD34+ and CD34dim/- neutrophil committed progenitors
F. Calzetti, G. Finotti, … M. A. Cassatella·bioRxiv·Apr 30, 2021
- The extracellular sialidase NEU3 induces neutrophil priming
S. A. Kirolos, R. H. Gomer·bioRxiv·Feb 23, 2022
- Ectodomain shedding of L-selectin by ADAM17 in canine neutrophils
K. M. Snyder, C. McAloney, … B. Walcheck·bioRxiv·Apr 6, 2020
- Endothelial Heterogeneity Across Vascular Beds Impacts Inflammatory Signaling and Neutrophil Adhesion
Eric L Ginter, Sunanda Mitra, Laurel E. Hind·bioRxiv·May 29, 2026
- Analysis of receptor-ligand pairings and distribution of myeloid subpopulations across the animal kingdom reveals neutrophil evolution was facilitated by colony-stimulating factors.
D. Pinheiro, M.-A. Mawhin, … K. J. Woollard·bioRxiv·Jun 19, 2020